Andreas Fibig

Andreas Fibig is currently Chairman at Max Planck Institute for Infection Biology, Independent Director at ExlService Holdings, Inc. since 2023, Executive Director at World Business Council for Sustainable Development, Director at European Federation of Pharmaceutical Industries & Assns, Honorary Director at German American Chamber of Commerce, Inc. since 2021, Director at Indigo Ag, Inc. since 2022, Director at Montai Therapeutics, Inc. since 2023, Director at EvodiaBio ApS since 2022, and Member at German Academy of New York.
Former positions include Chairman & Chief Executive Officer at International Flavors & Fragrances, Inc. from 2014 to 2022, Chairman at Bayer Pharma AG from 2008 to 2014, President & Chairman-Management Board at Bayer HealthCare Pharmaceuticals, Inc. from 2008 to 2014, Director-Sales & Marketing at Bayer Schering Pharma AG in 1984, Independent Director at Bunge Ltd. from 2016 to 2018, Director at Council of the Americas, Inc., Independent Director at Novo Nordisk A from 2018 to 2025, Senior VP-US Pharmaceutical Operations Group at Pfizer Inc. from 2007 to 2008, Principal at Boehringer Ingelheim GmbH in 2000, President-Market at Pharmacia GmbH from 2000 to 2003, and Member-Supervisory Board at Verband Forschender Arzneimittelhersteller eV.
Education includes an undergraduate degree from Hochschule für Wirtschaft und Recht Berlin, conferred in 1982.